v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Common stock
Additional paid-in capital
Accumulated deficit
Total
Balance at Dec. 31, 2024 $ 837,764 $ 101,319 $ (327,937) $ 611,146
Balance (in Shares) at Dec. 31, 2024 479,332,885      
Net loss (55,553) (55,553)
Stock-based compensation 4,268 4,268
Issuance of replacement stock-based compensation 232 232
Issuance of common shares $ 89,864 89,864
Issuance of common shares (in Shares) 74,311,252      
Issuance of equity warrants 11,477 11,477
Balance at Mar. 31, 2025 $ 927,628 117,296 (383,490) 661,434
Balance (in Shares) at Mar. 31, 2025 553,644,137      
Balance at Dec. 31, 2025 $ 1,064,572 108,284 (612,481) 560,375
Balance (in Shares) at Dec. 31, 2025 601,579,999      
Net loss (145,353) (145,353)
Stock-based compensation 3,664 3,664
Settlement of restricted share units $ 744 (744)
Settlement of restricted share units (in Shares) 932,275      
Exercise of stock options $ 693 (244) 449
Exercise of stock options (in Shares) 338,863      
Balance at Mar. 31, 2026 $ 1,066,009 $ 110,960 $ (757,834) $ 419,135
Balance (in Shares) at Mar. 31, 2026 602,851,137